Atlas Trials

A Clinical Pharmacology Study of JNS010 (Paliperidone Palmitate) in Patients With Schizophrenia

Clinical trial NCT01942382 · COMPLETED

Trial details

NCT number
NCT01942382
Sponsor
Janssen Pharmaceutical K.K.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Schizophrenia
Start date
2009-04-01
Primary completion
2010-03-01
Enrollment
76

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.